Biocon shareholders and shareholding pattern
NSE: BIOCONBSE: 532523Pharmaceuticals & BiotechnologyMid Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹350.70.
29 Oct: open ₹351.50, high ₹357.30, low ₹349.40
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹57,349 Cr173rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 115.79
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹399 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 64.11
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.69
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.14%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 1.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹399 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 31,13,378
Biocon's shareholding pattern for Sep 2026, filed on 21 Oct 2026, with every filing from Dec 2016: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Biocon, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters44.68%
- Foreign institutions8.64%
- Indian institutions29.30%
- Individuals and others17.20%
- Employee trusts0.19%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
- Employee trusts
| Per cent | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60.68% | 60.68% | 60.67% | 60.67% | 60.67% | 60.67% | 60.67% | 60.67% | 60.67% | 60.67% | 60.67% | 60.67% | 60.67% | 60.67% | 60.67% | 60.67% | 60.67% | 60.67% | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% | 54.45% | 54.45% | 54.45% | 44.91% | 44.68% | 44.68% | |
| Indian promoters | 39.88% | 39.88% | 39.82% | 39.82% | 39.80% | 39.77% | 39.77% | 39.77% | 39.77% | 39.77% | 39.77% | 39.77% | 39.77% | 39.75% | 39.75% | 39.75% | 39.75% | 39.75% | 39.73% | 39.73% | 39.73% | 39.73% | 39.73% | 39.66% | 39.66% | 39.66% | 39.66% | 40.36% | 40.36% | 40.36% | 40.36% | 40.36% | 40.36% | 40.36% | 36.24% | 36.24% | 36.24% | 29.90% | 29.73% | 29.73% |
| Foreign promoters | 20.80% | 20.80% | 20.85% | 20.85% | 20.87% | 20.90% | 20.90% | 20.90% | 20.90% | 20.90% | 20.90% | 20.90% | 20.90% | 20.92% | 20.92% | 20.92% | 20.92% | 20.92% | 20.91% | 20.91% | 20.91% | 20.91% | 20.91% | 20.98% | 20.98% | 20.98% | 20.98% | 20.28% | 20.28% | 20.28% | 20.28% | 20.28% | 20.28% | 20.28% | 18.21% | 18.21% | 18.21% | 15.02% | 14.94% | 14.94% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 37.53% | 37.55% | 37.55% | 37.66% | 37.77% | 37.83% | 37.84% | 38.01% | 38.04% | 37.90% | 37.99% | 38.00% | 38.07% | 38.10% | 38.20% | 38.31% | 38.35% | 38.40% | 38.45% | 38.64% | 38.71% | 38.74% | 38.63% | 38.74% | 38.78% | 38.81% | 38.87% | 38.97% | 39.03% | 39.05% | 39.08% | 39.12% | 39.14% | 39.15% | 45.37% | 45.41% | 45.43% | 55.00% | 55.27% | 55.14% |
| Employee trusts | 1.78% | 1.76% | 1.78% | 1.67% | 1.56% | 1.50% | 1.49% | 1.32% | 1.29% | 1.43% | 1.34% | 1.33% | 1.27% | 1.23% | 1.13% | 1.02% | 0.98% | 0.93% | 0.91% | 0.72% | 0.65% | 0.63% | 0.73% | 0.63% | 0.58% | 0.55% | 0.49% | 0.39% | 0.33% | 0.32% | 0.28% | 0.25% | 0.22% | 0.21% | 0.18% | 0.14% | 0.12% | 0.09% | 0.05% | 0.19% |
| Promoter shares pledgedShare of the promoters' own shares | 0.04% | 0.04% | 0.02% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Shares in issue | 20,00,00,000 | 20,00,00,000 | 60,00,00,000what Shares in issue, Jun 2017, includes. Bonus issue on 15 Jun 2017: 2 new shares for every 1 held. Earlier filings count the shares before it. | 60,00,00,000 | 60,00,00,000 | 60,00,00,000 | 60,00,00,000 | 60,00,00,000 | 60,00,00,000 | 60,00,00,000 | 1,20,00,00,000what Shares in issue, Jun 2019, includes. Bonus issue on 12 Jun 2019: 1 new share for every 1 held. Earlier filings count the shares before it. | 1,20,00,00,000 | 1,20,00,00,000 | 1,20,00,00,000 | 1,20,00,00,000 | 1,20,00,00,000 | 1,20,00,00,000 | 1,20,00,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,20,06,00,000 | 1,33,69,63,635 | 1,33,69,63,635 | 1,33,69,63,635 | 1,62,09,07,773 | 1,62,96,94,135 | 1,62,96,94,135 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | 17,12,79,553 | 20,34,29,031 | 3,21,49,478 |
| Promoters' shares locked in | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | 53,58,440 | 53,58,440 |
Biocon promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is KIRAN MAZUMDAR-SHAW, 29.73%. The filing names 4 more members with no shares.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| KIRAN MAZUMDAR-SHAWIndividuals and Hindu undivided families | 29.73% | 48,45,81,970 | 0.00% |
| GLENTEC INTERNATIONALForeign companies and others | 14.56% | 23,72,11,164 | 0.00% |
| RAVI RASENDRA MAZUMDARNon-resident and foreign individuals | 0.33% | 53,58,440 | 100.00% |
| DEV MAZUMDARNon-resident and foreign individuals | 0.06% | 9,29,721 | 0.00% |
Largest public holders of Biocon, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Biocon
| Holder | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SERUM INSTITUTE LIFE SCIENCES PRIVATE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.42% | 3.40% | 3.40% |
| LICI NEW PENSION PLUS GROWTH FUNDInsurance companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.87% | – | 2.62% |
| MYLAN INC.Foreign companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.67% | 5.64% | – |
| LIFE INSURANCE CORPORATION OF INDIAInsurance companies | – | – | – | – | – | – | – | – | – | – | – | – | 1.16% | 1.55% | 1.67% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.34% | – | – | – | – | – | 3.73% | – |
| ACTIV PINE LLPCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.09% | 1.08% | – |
| HDFC LIFE INSURANCE COMPANY LIMITEDInsurance companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.01% | – |
| LICI CHILD FORTUNE PLUS GROWTH FUNDInsurance companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.41% | 4.94% | – | – | – | 4.90% | – | 4.66% | – | – | – |
| LICI ULIP-GROWTH FUNDInsurance companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.25% | 4.25% | 4.25% | – | 4.41% | 4.41% | 4.41% | 4.41% | – | – | 5.09% | – | 5.34% | – | 4.90% | – | – | – | – |
| ARUN SURESH CHANDAVARKARResident individuals, over ₹2 lakh at face value | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | – | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | 1.10% | – | – | – | – | – | – |
| LIC ULIP-GROWTH FUNDInsurance companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.41% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| AHAN- I LTDForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | 1.30% | 1.66% | 1.66% | 1.66% | 1.66% | 1.66% | 1.66% | 1.66% | 1.66% | 2.33% | 2.33% | 2.33% | 2.33% | 2.15% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| AROHI EMERGING ASIA MASTER FUNDForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.56% | 1.56% | 1.56% | 1.56% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| LIFE INSURANCE CORPORATION OF INDIA ALONG WITH OTHER SCHEMESInsurance companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.24% | 4.24% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Life Insurance Corporation of India (LIC)Insurance companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.66% | 2.27% | 4.11% | 4.11% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SOCIETE GENERALEInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.01% | – | – | 1.01% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| JUPITER INDIA FUNDInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | – | – | – | – | – | 1.10% | 1.10% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| OPPENHEIMER DEVELOPING MARKETS FUNDInstitutions Foreign Portfolio Investor | 2.02% | 2.19% | 2.58% | 2.58% | 3.71% | 4.31% | 4.31% | 4.31% | 4.31% | 4.08% | 3.28% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| NATIONAL WESTMINSTER BANK PLC AS TRUSTEE OF THE JUInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | – | – | 1.16% | – | 1.10% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| NATIONAL WESTMINSTER BANK PLC AS TRUSTEE OF THE JUPITER INDIA FUNDInstitutions Foreign Portfolio Investor | – | – | 1.38% | 1.40% | 1.40% | 1.14% | 1.15% | 1.14% | – | 1.10% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| FRANKLIN TEMPLETON INVESTMENT FUNDSInstitutions Foreign Portfolio Investor | 1.81% | 1.71% | 1.71% | 1.46% | 1.12% | 1.11% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ARUN SURESHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | 1.10% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| MURALI KRISHNAN K NResident individuals, over ₹2 lakh at face value | 1.05% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Who moved in the Sep 2026 filing
Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Indian institutions: LIFE INSURANCE CORPORATION OF INDIA no longer named, from 3.73%; LICI NEW PENSION PLUS GROWTH FUND newly named at 2.62%; HDFC LIFE INSURANCE COMPANY LIMITED no longer named, from 1.01%
- Individuals and others: MYLAN INC. no longer named, from 5.64%; ACTIV PINE LLP no longer named, from 1.08%